AlloVir Inc. (ALVR): Price and Financial Metrics
ALVR Price/Volume Stats
| Current price | $0.40 | 52-week high | $2.36 |
| Prev. close | $0.45 | 52-week low | $0.40 |
| Day low | $0.40 | Volume | 1,054,600 |
| Day high | $0.47 | Avg. volume | 595,593 |
| 50-day MA | $0.66 | Dividend yield | N/A |
| 200-day MA | $0.74 | Market Cap | 46.69M |
ALVR Stock Price Chart Interactive Chart >
AlloVir Inc. (ALVR) Company Bio
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John Wilson, and Ann M. Leen in 2013 and is headquartered in Houston, TX.
ALVR Price Returns
| 1-mo | -29.82% |
| 3-mo | -47.75% |
| 6-mo | -48.71% |
| 1-year | -47.74% |
| 3-year | -97.06% |
| 5-year | N/A |
| YTD | -41.16% |
| 2023 | -86.75% |
| 2022 | -60.36% |
| 2021 | -66.34% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...